Effects of hyperthyroidism and hypothyroidism on human red blood cell Ca2+-ATPase activity. 1986

M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas

Erythrocyte Ca2+-ATPase activity was measured in membrane ghosts from hyperthyroid and hypothyroid patients and compared with that in normal subjects. Basal enzyme activity was significantly increased in the hyperthyroid group and decreased in the hypothyroid group. In vitro responsiveness of the enzyme to calmodulin, the activator protein for Ca2+-ATPase, and to T4 was decreased in both hyper- and hypothyroid ghosts. Although the membrane content of endogenous calmodulin was low in hypothyroidism, this is an unlikely explanation for the low basal activity of Ca2+-ATPase. A limited number of patients from each group were restudied when they were euthyroid after 8 or more months of treatment. Basal, T4-stimulated, and calmodulin-stimulated Ca2+-ATPase activities returned to normal, with the exception of calmodulin responsiveness in the membranes from previously hypothyroid patients. This decreased responsiveness may have been a reflection of either increased patient age or underlying chronic (non-thyroidal) illness. This study provides clinical confirmation of previously reported in vitro studies suggesting that the set-point of Ca2+-ATPase activity is, in part, a function of endogenous thyroid hormone levels.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007037 Hypothyroidism A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002147 Calmodulin A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium-Dependent Activator Protein,Calcium-Dependent Regulator,Bovine Activator Protein,Cyclic AMP-Phosphodiesterase Activator,Phosphodiesterase Activating Factor,Phosphodiesterase Activator Protein,Phosphodiesterase Protein Activator,Regulator, Calcium-Dependent,AMP-Phosphodiesterase Activator, Cyclic,Activating Factor, Phosphodiesterase,Activator Protein, Bovine,Activator Protein, Calcium-Dependent,Activator Protein, Phosphodiesterase,Activator, Cyclic AMP-Phosphodiesterase,Activator, Phosphodiesterase Protein,Calcium Dependent Activator Protein,Calcium Dependent Regulator,Cyclic AMP Phosphodiesterase Activator,Factor, Phosphodiesterase Activating,Protein Activator, Phosphodiesterase,Protein, Bovine Activator,Protein, Calcium-Dependent Activator,Protein, Phosphodiesterase Activator,Regulator, Calcium Dependent
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
October 1988, Hypertension (Dallas, Tex. : 1979),
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
January 1987, Klinische Wochenschrift,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
April 1983, Cell calcium,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
July 1990, Biochimica et biophysica acta,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
February 1980, Biochimica et biophysica acta,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
April 1981, Biochemical and biophysical research communications,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
March 1980, Biochimica et biophysica acta,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
January 1982, Endocrinology,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
January 1979, American journal of hematology,
M P Dube, and F B Davis, and P J Davis, and M Schoenl, and S D Blas
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!